Literature DB >> 3184125

Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity.

H Kagechika1, E Kawachi, Y Hashimoto, T Himi, K Shudo.   

Abstract

Two types of aromatic amides, terephthalic monoanilides and (arylcarboxamido)benzoic acids, have been shown to possess potent retinoidal activities and can be classified as retinoids. The structure-activity relationships of these amides are discussed on the basis of differentiation-inducing activity on human promyelocytic leukemia cells HL-60. In generic formula 4 (X = NHCO or CONH), the necessary factors to elicit the retinoidal activities are a medium-sized alkyl group (isopropyl, tert-butyl, etc.) at the meta position and a carboxyl group at the para position of the other benzene ring. The bonding of the amide structure can be reversed, this moiety apparently having the role of locating the two benzene rings at suitable positions with respect to each other. Substitution at the ring position ortho to the amide group or N-methylation of the amide group caused loss of activity, presumably owing to the resultant change of conformation. It is clear that the mutual orientation of the benzylic methyl group(s) and the carboxyl group and their distance apart are essential factors determining the retinoidal activity. Among the synthesized compounds, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benz oic acid (Am80) and 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carboxamido] benzoic acid (Am580) were several times more active than retinoic acid in the assay. They are structurally related to retinoic acid, as is clear from the biological activity of the hybrid compounds (M2 and R2).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3184125     DOI: 10.1021/jm00119a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.

Authors:  Q Wu; M I Dawson; Y Zheng; P D Hobbs; A Agadir; L Jong; Y Li; R Liu; B Lin; X K Zhang
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.

Authors:  Z Szondy; U Reichert; J M Bernardon; S Michel; R Tóth; E Karászi; L Fésüs
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Dual RXR Agonists and RAR Antagonists Based on the Stilbene Retinoid Scaffold.

Authors:  Claudio Martínez; Michele Lieb; Susana Alvarez; Fátima Rodríguez-Barrios; Rosana Alvarez; Harshal Khanwalkar; Hinrich Gronemeyer; Angel R de Lera
Journal:  ACS Med Chem Lett       Date:  2014-03-19       Impact factor: 4.345

Review 4.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

5.  Retinoic acid induces expression of the thyroid hormone transporter, monocarboxylate transporter 8 (Mct8).

Authors:  Takahiko Kogai; Yan-Yun Liu; Laura L Richter; Kaizeen Mody; Hiroyuki Kagechika; Gregory A Brent
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

6.  Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4.

Authors:  Y Hashimoto; H Kagechika; E Kawachi; H Fukasawa; G Saito; K Shudo
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.

Authors:  Y Lu; S Bertran; T-A Samuels; R Mira-y-Lopez; E F Farias
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

Review 8.  Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia.

Authors:  Akihiro Tomita; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2013-05-14       Impact factor: 2.490

9.  Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules.

Authors:  Lauren J Schwimmer; Priyanka Rohatgi; Bahareh Azizi; Katherine L Seley; Donald F Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

Review 10.  PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia.

Authors:  Kazunori Ohnishi
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.